Clever Leaves Holdings Inc (CLVR)
1.70
-0.03
(-1.73%)
USD |
NASDAQ |
May 03, 16:00
1.75
+0.05
(+2.94%)
After-Hours: 20:00
Clever Leaves Holdings Cash from Operations (Quarterly): -1.543M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.543M |
September 30, 2023 | -2.201M |
June 30, 2023 | -1.687M |
March 31, 2023 | -6.077M |
December 31, 2022 | -5.097M |
September 30, 2022 | -5.385M |
June 30, 2022 | -8.213M |
March 31, 2022 | -10.37M |
December 31, 2021 | -8.038M |
September 30, 2021 | -8.699M |
June 30, 2021 | -8.869M |
March 31, 2021 | -10.63M |
Date | Value |
---|---|
December 31, 2020 | -3.682M |
September 30, 2020 | -3.736M |
June 30, 2020 | -7.322M |
March 31, 2020 | -7.221M |
March 31, 2018 | 6.821M |
September 30, 2017 | 1.495M |
June 30, 2017 | 5.421M |
March 31, 2017 | 4.376M |
September 30, 2016 | -12.30M |
June 30, 2016 | -2.152M |
March 31, 2016 | 19.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.63M
Minimum
Mar 2021
-1.543M
Maximum
Dec 2023
-6.173M
Average
-6.649M
Median
Cash from Operations (Quarterly) Benchmarks
Tilray Brands Inc | -15.36M |
Flora Growth Corp | -1.131M |
Acasti Pharma Inc | -1.892M |
Aurinia Pharmaceuticals Inc | 14.31M |
Edesa Biotech Inc | -1.406M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 2.056M |
Cash from Financing (Quarterly) | -0.162M |
Free Cash Flow | -11.54M |
Free Cash Flow Per Share (Quarterly) | -0.8019 |
Free Cash Flow to Equity (Quarterly) | -1.269M |
Free Cash Flow to Firm (Quarterly) | -1.364M |
Free Cash Flow Yield | -433.1% |